Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$45.06

-0.36 (-0.79%)

05:21
09/03/19
09/03
05:21
09/03/19
05:21

AstraZeneca downgraded to Sell from Hold at DZ Bank

DZ Bank analyst Elmar Kraus downgraded AstraZeneca to Sell from Hold with a price target of 66 pounds.

  • 06

    Sep

  • 07

    Sep

  • 16

    Sep

  • 25

    Sep

  • 27

    Sep

  • 02

    Oct

AZN AstraZeneca
$45.06

-0.36 (-0.79%)

07/26/19
HCWC
07/26/19
NO CHANGE
HCWC
Amarin prepared to defend patents against Epanova launch, says H.C. Wainwright
After speaking with an intellectual property attorney, H.C. Wainwright analyst Andrew Fein believes Amarin (AMRN) has prepared itself to defend its patents for Vascepa against a possible launch of AstraZeneca's (AZN) omega-3 Epanova. The consultation revealed the FDA's Orange Book includes 25 patents listed for Vascepa, Fein tells investors in a research note. While, according to the IP attorney, Amarin's Orange Book patents do not appear to directly address Epanova, Amarin has a large patent portfolio in this space, says the analyst. Fein points out that Amarin could not hypothetically sue AstraZeneca for patent infringement until Epanova was made, used, or sold in a commercial context. These are not brand-generic circumstances between both companies, he writes. However, Fein thinks Amarin's patents could give it the upper hand and he reiterates a Buy rating on the shares with a $51 price target.
07/29/19
WBLR
07/29/19
NO CHANGE
WBLR
Outperform
Updates 'very positive' for upcoming Pieris presentation, says William Blair
Pieris Pharmaceuticals (PIRS) will present Phase Ib safety and efficacy results with PRS-060, an inhaled IL-4R alpha inhibitor, at the upcoming European Respiratory Society International Congress, held September 28 through October 2, William Blair analyst Matt Phipps tells investors in a research note. The poster presentation to be presented on October 1 is titled, "Multiple ascending dose study of the inhaled IL-4Ra antagonist, AZD1402/PRS-060, in mild asthmatics demonstrates robust FeNO reduction and a promising clinical profile for the treatment of asthma," the analyst point out. In addition, AstraZeneca (AZN) plans to initiate a Phase II trial with AZD1402/PRS-060 in the second half of this year, according to its recent earnings presentation, adds Phipps. He views these updates as "very positive" for the upcoming presentation, and believes PRS-060 has "significant potential" in the treatment of asthma patients. Phipps keeps an Outperform rating on Pieris Pharmaceuticals.
08/13/19
BOFA
08/13/19
DOWNGRADE
Target $7
BOFA
Neutral
Clovis downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill Tazeen Ahmad downgraded Clovis (CLVS) to Neutral and lowered his price target to $7 from $13 after last week's release of positive topline results for its PARP inhibitor Lynparza to treat prostate cancer by the company's competitor AstraZeneca (AZN). The analyst notes that the Lynparza update alters his expectations in the prostate cancer market to assume a two-player landscape from day one, reducing his expectations for Clovis's Rubraca peak sales to $250M from $406M with peak U.S. BRCA penetration of 15%.
08/14/19
ARGS
08/14/19
NO CHANGE
Target $50
ARGS
Buy
AstraZeneca price target raised to $50 from $46 at Argus
Argus analyst John Eade raised his price target on AstraZeneca to $50 and kept his Buy rating, saying the stock has outperformed over the past quarter thanks to the pipeline developments that are returning the company to growth. The analyst notes that the company's future growth should be driven by its checkpoint inhibitor Imfinzi, and he sees the program tracking toward a billion-dollar blockbuster status from $338M reported in Q2. Eade further notes that AstraZeneca management has made efforts to address the ongoing pricing pressure and generic threats to its former blockbusters Nexium and Crestor by reducing costs and assembling a new drug pipeline.

TODAY'S FREE FLY STORIES

AMD

AMD

$30.04

(0.00%)

, NKE

Nike

$86.69

(0.00%)

09:40
09/23/19
09/23
09:40
09/23/19
09:40
Options
Unusually active option classes on open September 23rd »

Unusual total active…

AMD

AMD

$30.04

(0.00%)

NKE

Nike

$86.69

(0.00%)

SLV

iShares Silver Trust

$16.80

(0.00%)

GDX

VanEck Vectors Gold Miners ETF

$28.67

(0.00%)

XLNX

Xilinx

$96.45

(0.00%)

AMAT

Applied Materials

$50.92

(0.00%)

MRK

Merck

$85.17

(0.00%)

X

U.S. Steel

$10.81

(0.00%)

WORK

Slack Technologies

$25.39

(0.00%)

BMY

Bristol-Myers

$50.56

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 02

    Oct

  • 02

    Oct

  • 03

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 31

    Oct

  • 07

    Nov

  • 14

    Mar

FB

Facebook

$189.88

-0.27 (-0.14%)

, SNAP

Snap

$17.05

0.18 (1.07%)

09:39
09/23/19
09/23
09:39
09/23/19
09:39
Periodicals
Snap detailed Facebook's hardball tactics in 'Voldemort' dossier, WSJ reports »

Facebook's (FB)…

FB

Facebook

$189.88

-0.27 (-0.14%)

SNAP

Snap

$17.05

0.18 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

FNKO

Funko

$21.88

-1.48 (-6.34%)

09:37
09/23/19
09/23
09:37
09/23/19
09:37
Recommendations
Funko analyst commentary  »

DA Davidson reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APY

Apergy

$29.42

0.07 (0.24%)

, BAS

Basic Energy

$1.89

0.45 (31.25%)

09:36
09/23/19
09/23
09:36
09/23/19
09:36
Conference/Events
Johnson Rice to hold a conference »

Energy Conference will be…

APY

Apergy

$29.42

0.07 (0.24%)

BAS

Basic Energy

$1.89

0.45 (31.25%)

CHAP

Chaparral Energy

$1.77

-0.025 (-1.39%)

DNR

Denbury Resources

$1.29

-0.045 (-3.38%)

EPM

Evolution Petroleum

$5.88

0.23 (4.07%)

FET

Forum Energy

$1.75

-0.04 (-2.23%)

GDP

Goodrich Petroleum

$11.14

0.04 (0.36%)

HLX

Helix Energy

$8.28

-0.145 (-1.72%)

ICD

Independence Contract Drilling

$1.73

0.14 (8.81%)

KEG

Key Energy

$1.60

-0.015 (-0.93%)

LLEX

Lilis Energy

$0.39

0.0095 (2.52%)

MDR

McDermott

$2.01

0.43 (27.22%)

NBL

Noble Energy

$23.15

-0.15 (-0.64%)

OAS

Oasis Petroleum

$3.95

0.01 (0.25%)

PDCE

PDC Energy

$30.46

-1.06 (-3.36%)

REI

Ring Energy

$1.82

0.23 (14.51%)

RE

Everest Re

$264.50

2.26 (0.86%)

SBOW

SilverBow Resources

$10.29

-0.21 (-2.00%)

SDPI

Superior Drilling

$0.83

-0.004 (-0.48%)

TUSK

Mammoth Energy

$2.98

0.03 (1.02%)

USWS

U.S. Well Services

$2.17

-0.12 (-5.24%)

WTTR

Select Energy Services

$9.02

0.11 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 23

    Sep

  • 25

    Sep

  • 02

    Oct

  • 02

    Oct

  • 29

    Oct

  • 07

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

BAC

Bank of America

$29.57

-0.23 (-0.77%)

, BK

BNY Mellon

$46.38

-0.61 (-1.30%)

09:35
09/23/19
09/23
09:35
09/23/19
09:35
Conference/Events
U.S. Treasury Department to co-host a conference »

The U.S. Treasury Dept,…

BAC

Bank of America

$29.57

-0.23 (-0.77%)

BK

BNY Mellon

$46.38

-0.61 (-1.30%)

BLK

BlackRock

$444.61

0.64 (0.14%)

CS

Credit Suisse

$12.81

-0.05 (-0.39%)

FNMA

Fannie Mae

$0.00

(0.00%)

GS

Goldman Sachs

$213.76

-1.59 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 15

    Oct

  • 16

    Oct

  • 16

    Oct

  • 27

    Oct

09:35
09/23/19
09/23
09:35
09/23/19
09:35
General news
Breaking General news story  »

New York Federal Reserve…

HUN

Huntsman

$22.49

-0.3 (-1.32%)

09:34
09/23/19
09/23
09:34
09/23/19
09:34
Upgrade
Huntsman rating change  »

Huntsman upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

NFLX

Netflix

$270.66

-15.92 (-5.56%)

09:33
09/23/19
09/23
09:33
09/23/19
09:33
Recommendations
Netflix analyst commentary  »

Release of The Irishman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 16

    Oct

GEL

Genesis Energy

$22.27

-0.43 (-1.89%)

09:32
09/23/19
09/23
09:32
09/23/19
09:32
Hot Stocks
Genesis Energy announces expansion of existing sodium services operations »

Genesis Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
09/23/19
09/23
09:30
09/23/19
09:30
General news
PMI Composite FLASH Manufacturing â€' Level to be reported at 09:45 »

September PMI Composite…

09:30
09/23/19
09/23
09:30
09/23/19
09:30
General news
PMI Composite FLASH â€' Level to be reported at 09:45 »

September PMI Composite…

SEV

Sevcon

$0.00

(0.00%)

, XYL

Xylem

$77.61

-0.38 (-0.49%)

09:29
09/23/19
09/23
09:29
09/23/19
09:29
Conference/Events
RBC Capital to hold booth tours and meetings at conference »

RBC Capital Company Booth…

SEV

Sevcon

$0.00

(0.00%)

XYL

Xylem

$77.61

-0.38 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 31

    Oct

MED

Medifast

$108.05

1.52 (1.43%)

09:28
09/23/19
09/23
09:28
09/23/19
09:28
Recommendations
Medifast analyst commentary  »

Medifast CFO confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FELE

Franklin Electric

$46.86

-0.66 (-1.39%)

, WTS

Watts Water

$95.13

-0.94 (-0.98%)

09:28
09/23/19
09/23
09:28
09/23/19
09:28
Conference/Events
Seaport Global to hold booth tours at conference »

Seaport Global Company…

FELE

Franklin Electric

$46.86

-0.66 (-1.39%)

WTS

Watts Water

$95.13

-0.94 (-0.98%)

XYL

Xylem

$77.61

-0.38 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 31

    Oct

  • 18

    Nov

FSLR

First Solar

$66.69

-0.4 (-0.60%)

09:27
09/23/19
09/23
09:27
09/23/19
09:27
Hot Stocks
First Solar announces 25GW DC of photovoltaic modules shipped »

First Solar is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:27
09/23/19
09/23
09:27
09/23/19
09:27
Conference/Events
Water Environment Federation to hold a conference »

WEFTEC 2019 will be held…

09:26
09/23/19
09/23
09:26
09/23/19
09:26
Conference/Events
Barclays to hold a forum »

Payments & FinTech…

ADBE

Adobe

$277.84

-3.37 (-1.20%)

, ADP

ADP

$159.15

-0.15 (-0.09%)

09:26
09/23/19
09/23
09:26
09/23/19
09:26
Conference/Events
PagerDuty to hold a summit »

PagerDuty Summit 2019…

ADBE

Adobe

$277.84

-3.37 (-1.20%)

ADP

ADP

$159.15

-0.15 (-0.09%)

AMZN

Amazon.com

$1,793.64

-28.57 (-1.57%)

GOOG

Alphabet

$1,229.57

-10.03 (-0.81%)

IBM

IBM

$141.82

-1.17 (-0.82%)

MSFT

Microsoft

$139.34

-1.74 (-1.23%)

TWLO

Twilio

$114.39

-0.74 (-0.64%)

UBER

Uber

$32.52

-1.31 (-3.87%)

WORK

Slack Technologies

$25.39

-0.375 (-1.46%)

ZEN

Zendesk

$77.73

0.275 (0.36%)

ZM

Zoom Video

$82.68

-1.91 (-2.26%)

PD

PagerDuty

$29.89

0.785 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 13

    Nov

FQVLF

First Quantum Minerals

$0.00

(0.00%)

09:25
09/23/19
09/23
09:25
09/23/19
09:25
Hot Stocks
First Quantum granted right to enter option agreement on Dragonslayer project »

Millrock Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVCY

Central Valley Community

$21.49

0.88 (4.27%)

09:24
09/23/19
09/23
09:24
09/23/19
09:24
Downgrade
Central Valley Community rating change  »

Central Valley Community…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIVE

Five Below

$126.54

-1.89 (-1.47%)

09:23
09/23/19
09/23
09:23
09/23/19
09:23
Recommendations
Five Below analyst commentary  »

Five Below's Ten…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$154.15

0.73 (0.48%)

09:22
09/23/19
09/23
09:22
09/23/19
09:22
Hot Stocks
Hershey completes acquisition of ONE Brands for $397M »

The Hershey Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Healthcare

$124.35

-2.51 (-1.98%)

09:20
09/23/19
09/23
09:20
09/23/19
09:20
Hot Stocks
HCA Healthcare CHRO John Steele to retire, Jennifer Berres to succeed »

HCA Healthcare announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

REGN

Regeneron

$295.79

9.51 (3.32%)

, SNY

Sanofi

$46.50

1.61 (3.59%)

09:20
09/23/19
09/23
09:20
09/23/19
09:20
Upgrade
Regeneron, Sanofi, Roche rating change  »

Guggenheim upgrades…

REGN

Regeneron

$295.79

9.51 (3.32%)

SNY

Sanofi

$46.50

1.61 (3.59%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

  • 04

    Nov

SVMK

SurveyMonkey

$18.14

-0.16 (-0.87%)

09:20
09/23/19
09/23
09:20
09/23/19
09:20
Hot Stocks
SurveyMonkey achieves ISO recognition from the British Standards Institute »

SurveyMonkey announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.